All In MedTech

Device Trial Radar · NCT05778851

Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population

Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population (ASBE) A Randomized Controlled, Virtual Patient Trial

Last checked: Nov 20, 2026Latest source record: Oct 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

97

Actual

Start

Apr 12, 2023

Primary completion

Jul 31, 2024

Study completion Aug 19, 2024

Sponsor

Lead sponsor
Lucid Diagnostics, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Medex15
First posted
Mar 21, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Sequential
Masking
Single (participant)
Primary purpose
Screening
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This will be a prospective randomized, controlled, virtual, patient study to measure the impact of EsoCheck/EsoGuard on health care provider's decision for upper endoscopy referral. The participants will complete two rounds of questions concerning the assessed risk for BE and decision for endoscopy referral of 6 patient cases (clinical vignettes). After the first round has been completed, an EsoCheck/EsoGuard educational information package and the second round of 6 clinical vignettes including EsoGuard results will be sent.

Conditions

  • Barrett Esophagus

Interventions

  • EsoGuard resultDevice

    Education slide-set EsoGuard and patient cases including EsoGuard result

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Impact of EsoCheck/EsoGuard on Provider's Decision for Upper Endoscopy ReferralTime frame: 1 month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Lucid Diagnostics

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.